Day: January 27, 2021

Press ReleaseOoredoo Algeria deploys Nokia’s cloud-native core software to prepare for the future      ·Rollout to transform Ooredoo Algeria’s mobile network customer experience with better capacity and reliability, and enhanced product innovation and services 27 January 2021Espoo, Finland – Ooredoo Algeria has deployed Nokia’s cloud-native Core software to cost effectively strengthen its network performance and reliability, and to strategically position itself for the future and the launch of new services to meet customer needs. This deployment will further improve the digital ecosystem of the country.By modernizing its core to a more efficient, cloud-based network, with near-zero-touch automation capabilities and high-level operational efficiencies, Ooredoo Algeria can meet rising customer demand for much greater bandwidth capacity...

PLANO, Texas, Jan. 26, 2021 (GLOBE NEWSWIRE) — DZS Inc. (NASDAQ: DZSI) (the “Company” or “DZS”) today announced that it has priced its underwritten registered public offering of 4,000,000 shares of its common stock at a price to the public of $14.00 per share. The Company has granted the underwriters a 30-day option to purchase at the public offering price, less the underwriting discount, up to an additional 600,000 shares of common stock. All shares of common stock to be sold in the offering will be offered by the Company. The offering is expected to close on or about January 29, 2021.   The total gross proceeds from the offering are expected to be approximately $56 million. This amount assumes no exercise of the underwriters’ option to purchase additional shares. The Company intends to use the net proceeds from the offering to...

TORTOLA, British Virgin Islands, Jan. 26, 2021 (GLOBE NEWSWIRE) — Orca Energy Group Inc. (“Orca” or the “Company” and includes its subsidiaries and affiliates) (TSX-V: ORC.A, ORC.B) today is announcing that it has taken up 6,153,846 Class B Subordinate Voting Shares (“Class B Shares“) at a price of CDN$6.50 per Class B Share under Orca’s substantial issuer bid to purchase for cancellation a number of its Class B Shares for an aggregate purchase price not to exceed CDN$40 million (the “Offer“) and paid to AST Trust Company (Canada) (the “Depositary“) the purchase price proceeds. All dollar amounts are in Canadian dollars.The Class B Shares purchased represent an aggregate purchase price of approximately CDN$40 million and represent 25.2% of the total number of Orca’s...

Achieved 100% 1P Reserves ReplacementAdded 8.3 MMBOE of 1P ReservesRealized 1P Finding and Development Costs of $2.65/boe1P and 2P Net Asset Value per Share Before Tax of $1.15 and $3.251P Reserves Equal 59% of 2P Reserves, Demonstrating Strength of Company’s Proved Reserves BaseAchieved Company’s Best Safety Year in 2020: Zero Lost Time Incident FrequencyCALGARY, Alberta, Jan. 26, 2021 (GLOBE NEWSWIRE) — Gran Tierra Energy Inc. (“Gran Tierra” or the “Company“) (NYSE American:GTE) (TSX:GTE) (LSE: GTE), a company focused on oil exploration and production in Colombia and Ecuador, today announced the Company’s 2020 year-end reserves as evaluated by the Company’s independent qualified reserves evaluator McDaniel & Associates Consultants Ltd. (“McDaniel”) in a report with...

TORONTO, Jan. 26, 2021 (GLOBE NEWSWIRE) — iSIGN Media Solutions Inc. (“iSIGN” or “Company”) (TSX-V: ISD) (OTC: ISDSF), a leading provider of interactive mobile proximity marketing and public security alert solutions announced that it has closed the second tranche (the “Second Tranche”) of its previously announced non-brokered private placement (“Placement”) of up to $236,700.The Company completed the Second Tranche of the Placement for total gross proceeds of $20,000 by issuing 400,000 Units (“Units”) at a price of $0.05 per Unit. Each Unit consists of one Common Share of the Company (each a “Common Share”, collectively, the “Common Shares”) and one common share purchase warrant (each warrant referred to herein as a “Warrant” and collectively, the “Warrants”). Each Warrant entitles the holder to purchase one Common Share at a price...

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Jan. 26, 2021 (GLOBE NEWSWIRE) — Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: A2PL) (“Nabis” or the “Company“) today announced that it has completed its previously announced proposal (the “Proposal“) under the Bankruptcy and Insolvency Act (Canada), pursuant to which the Company implemented a recapitalization of its previously outstanding CDN$35 million principal amount of 8.0% unsecured convertible debentures (the “Debentures“) and all other prior debts of the Company (the “Recapitalization“).Upon implementation of the Proposal, (i) all existing equity claims in the Company were irrevocably and finally extinguished; and (ii) in full and final satisfaction...

PALOS VERDES ESTATES, Calif., Jan. 26, 2021 (GLOBE NEWSWIRE) — Malaga Financial Corporation, “Company” (OTCPink:MLGF), the parent company of Malaga Bank FSB, today reported that net income for the twelve months ended December 31, 2020 was $18,335,000 ($2.38 basic and fully diluted earnings per share) compared to $15,387,000 ($2.01 basic and $2.00 fully diluted earnings per share, as adjusted for the stock dividend declared on November 13, 2020) for the twelve months ended December 31, 2019, a 19% increase. Net income for the quarter ended December 31, 2020 was $4,743,000 ($0.62 basic and fully diluted earnings per share), an increase of $456,000 or 11% from net income of $4,287,000 for the quarter ended December 31, 2019 ($0.56 basic and fully diluted earnings per share, as adjusted for the stock dividend declared on November 13,...

First three patients discharged from Hospital ICU within 8 days from initial IV administration  No infusion-related adverse events noted for any patient treated to date SAN DIEGO, Jan. 26, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced today positive preliminary results from its Phase 1b study of human allogeneic adipose-derived mesenchymal stem cells (COVI-MSC™) for patients suffering from COVID-19-induced acute respiratory distress (ARD) or acute respiratory distress syndrome (ARDS). This ongoing study (PSC-CP-004) is a single arm, non-randomized Phase 1b study of the safety and preliminary efficacy of COVI-MSCs administered every other day for three infusions for a total of 1 x 106 cells/kg. The primary objective is to evaluate the safety of intravenous infusion of allogeneic...